News · 26 weeks84-7%
2025-12-142026-06-07
Mix3790d
- Insider21(57%)
- SEC Filings9(24%)
- Other3(8%)
- Earnings2(5%)
- Offering1(3%)
- Dividends1(3%)
Latest news
25 items- INSIDERCEO and President Davis J. E. sold $1,941,400 worth of shares (10,000 units at $194.14) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 132,423 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Carter Robert B was granted 1,142 shares, increasing direct ownership by 42% to 3,853 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Gregg Vicky B was granted 1,142 shares, increasing direct ownership by 7% to 18,314 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Main Timothy L was granted 1,142 shares, increasing direct ownership by 4% to 27,439 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Diaz Luis was granted 1,142 shares, increasing direct ownership by 28% to 5,196 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Wentworth Timothy C was granted 1,142 shares, increasing direct ownership by 529% to 1,358 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Doi Tracey was granted 1,142 shares, increasing direct ownership by 17% to 7,748 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Ring Timothy M was granted 1,142 shares, increasing direct ownership by 4% to 31,140 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Lassiter Wright Iii was granted 1,142 shares, increasing direct ownership by 12% to 10,317 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Morrison Denise M was granted 1,142 shares, increasing direct ownership by 11% to 11,929 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Pfeiffer Gary M was granted 1,142 shares, increasing direct ownership by 4% to 31,005 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- SECQuest Diagnostics Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - QUEST DIAGNOSTICS INC (0001022079) (Filer)
- PRQuest Diagnostics Declares Quarterly Cash DividendSECAUCUS, N.J., May 19, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on July 22, 2026 to shareholders of record of Quest Diagnostics common stock on July 8, 2026. About Quest DiagnosticsQuest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter,
- SECQuest Diagnostics Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - QUEST DIAGNOSTICS INC (0001022079) (Filer)
- SECQuest Diagnostics Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - QUEST DIAGNOSTICS INC (0001022079) (Filer)
- SECSEC Form FWP filed by Quest Diagnostics IncorporatedFWP - QUEST DIAGNOSTICS INC (0001022079) (Subject)
- PRQuest Diagnostics Prices $500 Million of Senior NotesSECAUCUS, N.J., April 27, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX) (the "Company"), a leader in diagnostic information services, today announced the pricing of a public offering of $500 million aggregate principal amount of its 5.000% senior notes due 2036 (the "Notes") under Quest Diagnostics' shelf registration statement. Quest Diagnostics expects to receive the net offering proceeds upon closing on May 6, 2026, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering for general corporate
- INSIDERExecutive Vice President & CFO Samad Sam was granted 108 shares, increasing direct ownership by 0.32% to 33,376 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.32% to 15,247 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Gregg Vicky B was granted 68 shares, increasing direct ownership by 0.40% to 17,172 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Carter Robert B increased direct ownership by 0.26% to 2,711 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERDirector Lassiter Wright Iii increased direct ownership by 0.07% to 9,063 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERSVP, Clinical Solutions Kuppusamy Karthik increased direct ownership by 0.29% to 13,490 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- INSIDERSVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.31% to 11,901 units (SEC Form 4)4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)
- SECSEC Form 10-Q filed by Quest Diagnostics Incorporated10-Q - QUEST DIAGNOSTICS INC (0001022079) (Filer)
DGX FAQ
7 questionsWhat does Quest Diagnostics Incorporated do?
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers...Where does DGX stock trade?
Quest Diagnostics Incorporated (DGX) is listed on NYSE.What sector and industry is DGX in?
Quest Diagnostics Incorporated operates in the Health Care sector, Medical Specialities industry.Does DGX pay a dividend?
Yes. DGX's next ex-dividend date is 2026-07-08 with a declared cash dividend of $0.86 per share, payable 2026-07-22.What are analysts saying about DGX?
Quest Diagnostics Incorporated has had 8 recent analyst actions on file. The most recent action was from Barclays: Overweight on 2026-01-30.What companies are similar to DGX?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare DGX side-by-side with any of them on Quantisnow.How can I track DGX on Quantisnow?
Quantisnow aggregates Quest Diagnostics Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DGX to receive live email and push alerts on every new disclosure.